NAT-based detection of mycoplasmas in biopharmaceuticals
[NAT-based detection of mycoplasmas in biopharmaceuticals]
EPTIS factsheet 1140765 | Last revision 2024-01-17 | URL: https://www.eptis.bam.de/pts1140765 https://www.eptis.bam.de/pts1140765
| PT provider | ||||||||||
| PT provider | Minerva Biolabs GmbH Minerva Biolabs GmbH | |||||||||
| Based in | Germany | |||||||||
| Language(s) | English | |||||||||
| Remarks | ||||||||||
| Keywords | ||||||||||
| Product groups |
Pharmaceutical products, drugs
|
|||||||||
| Testing fields |
Microbiology
|
|||||||||
| Technical details | ||||||||||
|
||||||||||
| Aims of the PT scheme | ||||||||||
| Target group of participants | Product release test laboratories | |||||||||
| Linked to specific legislation / standards | EP 2.6.7, JP G3, USP <1071> | |||||||||
| Additional, subsidiary aims | validation of testing methods | |||||||||
| Number of participants | 20 | |||||||||
| Accredited or otherwise reviewed by a 3rd party | ||||||||||
| Operation is commissioned / requested by | ||||||||||
| Fees and frequency | ||||||||||
| Participation fee | 280 € | |||||||||
| Regularly operated | Yes (annually) | |||||||||
| Year of first operation | 2013 | |||||||||
| Contact details of the PT provider | ||||||||||
| Provider | Contact person | |||||||||
|
Minerva Biolabs GmbH
Schkopauer Ring 13 12681 Berlin Germany Phone: +49 30 20004370 Fax: Web: http://www.minerva-biolabs.com http://www.minerva-biolabs.com |
Dr Dirk Vollenbroich
Phone: +49-30-20004370 Fax: Email: ipt@minerva-biolabs.com ipt@minerva-biolabs.com |
|||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in Germany,
Mr Johannes van de Kreeke.
Mr Johannes van de Kreeke.